SMAD1 and prostate carcinoma: PI3K/Akt-NF-kappaB signaling may promote prostate cancer (PC) bone metastasis in part by regulating transcription and activation of BMP2 and subsequent phosphorylation of Smad1/5/8 which are critical downstream targets of BMP2 signaling [30].